X0708 D LIVE 0001797409 Cambrian BioPharma Inc 228 Park Avenue South Suite 66643 NEW YORK NY NEW YORK 10003 (516) 962-3186 DELAWARE Cambrian BioPharma Inc. Corporation true James Peyer 228 Park Avenue South Suite 66643 New York NY NEW YORK 10003 Executive Officer Director Juliette Han 228 Park Avenue South Suite 66643 New York NY NEW YORK 10003 Executive Officer Director Mark Nuttall 228 Park Avenue South Suite 66643 New York NY NEW YORK 10003 Executive Officer Ruth Thieroff-Ekerdt 228 Park Avenue South Suite 66643 New York NY NEW YORK 10003 Executive Officer William DeVaul 228 Park Avenue South Suite 66643 New York NY NEW YORK 10003 Executive Officer Christian Angermeyer Centris Business Gateway, Level 0-C Triq Is-Salib tal-Imriehel, Zone 3, CBD Birkirkara O1 MALTA CBD 3020 Director Maryanna Saenko 465 First Street Los Altos CA CALIFORNIA 94022 Director Brenton L. Saunders 400 Somerset Corporate Boulevard Bridgewater NJ NEW JERSEY 08807 Director Paul Farr 201 Santa Monica Boulevard Santa Monica CA CALIFORNIA 90401 Director Martin Gunhaga Vastra Kyrkogatan 1 A Umea V7 SWEDEN SE-903 29 Director Lorin Van Nuland Centris Business Gateway, Level 0/C Triq Is-Salib tal-Imriehel, Zone 3, CBD Birkirkara O1 MALTA CBD 3020 Director Biotechnology Decline to Disclose 06c false 2026-06-30 false true true 46,210,122 shares were offered in a business combination whereby the Issuer issued 7,988,207 Common and 38,221,915 Preferred shares to shareholders of a certain company in exchange for their shares, increasing the Issuer's ownership to 100%. 0 129751064 123751064 6000000 false 80 0 0 0 false Cambrian BioPharma Inc /s/ William DeVaul William DeVaul Chief Legal Officer 2026-07-15